Global Gene Therapy in Oncology Market Growth (Status and Outlook) 2025-2031
According to this study, the global Gene Therapy in Oncology market size will reach US$ million by 2031.
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy in Oncology Industry Forecast” looks at past sales and reviews total world Gene Therapy in Oncology sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy in Oncology sales for 2025 through 2031. With Gene Therapy in Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in Oncology industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy in Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in Oncology.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in Oncology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Gene Therapy in Oncology Industry Forecast” looks at past sales and reviews total world Gene Therapy in Oncology sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy in Oncology sales for 2025 through 2031. With Gene Therapy in Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy in Oncology industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy in Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy in Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy in Oncology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy in Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy in Oncology.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy in Oncology market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Ex Vivo
- In Vivo
- Hospitals
- Diagnostics Centers
- Research Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol-Myers Squibb
- Cold Genesys
- Advantagene
- Amgen
- AstraZeneca
- Bio-Path Holdings
- CRISPR Therapeutics
- Editas Medicine
- Geron Corp
- Idera Pharmaceuticals
- Intellia Therapeutics
- Johnson & Johnson
- Marsala Biotech
- Merck
- Mologen AG
- Oncolytics Biotech
- Oncosec
- Oncotelic
- Shenzhen SiBiono GeneTech
- Sillajen BiOthersapeutics
- Tocagen
- UniQure
- Ziopharm Oncology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in Oncology Market Size (2020-2031)
2.1.2 Gene Therapy in Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy in Oncology by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy in Oncology Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy in Oncology Market Size by Type
2.3.1 Gene Therapy in Oncology Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy in Oncology Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Research Institutes
2.5 Gene Therapy in Oncology Market Size by Application
2.5.1 Gene Therapy in Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
3 GENE THERAPY IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Gene Therapy in Oncology Market Size Market Share by Player
3.1.1 Global Gene Therapy in Oncology Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN ONCOLOGY BY REGION
4.1 Gene Therapy in Oncology Market Size by Region (2020-2025)
4.2 Global Gene Therapy in Oncology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy in Oncology Market Size Growth (2020-2025)
4.4 APAC Gene Therapy in Oncology Market Size Growth (2020-2025)
4.5 Europe Gene Therapy in Oncology Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy in Oncology Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy in Oncology Market Size by Country (2020-2025)
5.2 Americas Gene Therapy in Oncology Market Size by Type (2020-2025)
5.3 Americas Gene Therapy in Oncology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in Oncology Market Size by Region (2020-2025)
6.2 APAC Gene Therapy in Oncology Market Size by Type (2020-2025)
6.3 APAC Gene Therapy in Oncology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in Oncology Market Size by Country (2020-2025)
7.2 Europe Gene Therapy in Oncology Market Size by Type (2020-2025)
7.3 Europe Gene Therapy in Oncology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in Oncology by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy in Oncology Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy in Oncology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN ONCOLOGY MARKET FORECAST
10.1 Global Gene Therapy in Oncology Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy in Oncology Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy in Oncology Forecast
10.1.3 APAC Gene Therapy in Oncology Forecast
10.1.4 Europe Gene Therapy in Oncology Forecast
10.1.5 Middle East & Africa Gene Therapy in Oncology Forecast
10.2 Americas Gene Therapy in Oncology Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy in Oncology Forecast
10.2.2 Canada Market Gene Therapy in Oncology Forecast
10.2.3 Mexico Market Gene Therapy in Oncology Forecast
10.2.4 Brazil Market Gene Therapy in Oncology Forecast
10.3 APAC Gene Therapy in Oncology Forecast by Region (2026-2031)
10.3.1 China Gene Therapy in Oncology Market Forecast
10.3.2 Japan Market Gene Therapy in Oncology Forecast
10.3.3 Korea Market Gene Therapy in Oncology Forecast
10.3.4 Southeast Asia Market Gene Therapy in Oncology Forecast
10.3.5 India Market Gene Therapy in Oncology Forecast
10.3.6 Australia Market Gene Therapy in Oncology Forecast
10.4 Europe Gene Therapy in Oncology Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy in Oncology Forecast
10.4.2 France Market Gene Therapy in Oncology Forecast
10.4.3 UK Market Gene Therapy in Oncology Forecast
10.4.4 Italy Market Gene Therapy in Oncology Forecast
10.4.5 Russia Market Gene Therapy in Oncology Forecast
10.5 Middle East & Africa Gene Therapy in Oncology Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy in Oncology Forecast
10.5.2 South Africa Market Gene Therapy in Oncology Forecast
10.5.3 Israel Market Gene Therapy in Oncology Forecast
10.5.4 Turkey Market Gene Therapy in Oncology Forecast
10.6 Global Gene Therapy in Oncology Forecast by Type (2026-2031)
10.7 Global Gene Therapy in Oncology Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy in Oncology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Cold Genesys
11.2.1 Cold Genesys Company Information
11.2.2 Cold Genesys Gene Therapy in Oncology Product Offered
11.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Cold Genesys Main Business Overview
11.2.5 Cold Genesys Latest Developments
11.3 Advantagene
11.3.1 Advantagene Company Information
11.3.2 Advantagene Gene Therapy in Oncology Product Offered
11.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Advantagene Main Business Overview
11.3.5 Advantagene Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Gene Therapy in Oncology Product Offered
11.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Gene Therapy in Oncology Product Offered
11.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bio-Path Holdings
11.6.1 Bio-Path Holdings Company Information
11.6.2 Bio-Path Holdings Gene Therapy in Oncology Product Offered
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bio-Path Holdings Main Business Overview
11.6.5 Bio-Path Holdings Latest Developments
11.7 CRISPR Therapeutics
11.7.1 CRISPR Therapeutics Company Information
11.7.2 CRISPR Therapeutics Gene Therapy in Oncology Product Offered
11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CRISPR Therapeutics Main Business Overview
11.7.5 CRISPR Therapeutics Latest Developments
11.8 Editas Medicine
11.8.1 Editas Medicine Company Information
11.8.2 Editas Medicine Gene Therapy in Oncology Product Offered
11.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Editas Medicine Main Business Overview
11.8.5 Editas Medicine Latest Developments
11.9 Geron Corp
11.9.1 Geron Corp Company Information
11.9.2 Geron Corp Gene Therapy in Oncology Product Offered
11.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Geron Corp Main Business Overview
11.9.5 Geron Corp Latest Developments
11.10 Idera Pharmaceuticals
11.10.1 Idera Pharmaceuticals Company Information
11.10.2 Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Idera Pharmaceuticals Main Business Overview
11.10.5 Idera Pharmaceuticals Latest Developments
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Information
11.11.2 Intellia Therapeutics Gene Therapy in Oncology Product Offered
11.11.3 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Intellia Therapeutics Main Business Overview
11.11.5 Intellia Therapeutics Latest Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Information
11.12.2 Johnson & Johnson Gene Therapy in Oncology Product Offered
11.12.3 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Johnson & Johnson Main Business Overview
11.12.5 Johnson & Johnson Latest Developments
11.13 Marsala Biotech
11.13.1 Marsala Biotech Company Information
11.13.2 Marsala Biotech Gene Therapy in Oncology Product Offered
11.13.3 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Marsala Biotech Main Business Overview
11.13.5 Marsala Biotech Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Gene Therapy in Oncology Product Offered
11.14.3 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Mologen AG
11.15.1 Mologen AG Company Information
11.15.2 Mologen AG Gene Therapy in Oncology Product Offered
11.15.3 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mologen AG Main Business Overview
11.15.5 Mologen AG Latest Developments
11.16 Oncolytics Biotech
11.16.1 Oncolytics Biotech Company Information
11.16.2 Oncolytics Biotech Gene Therapy in Oncology Product Offered
11.16.3 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Oncolytics Biotech Main Business Overview
11.16.5 Oncolytics Biotech Latest Developments
11.17 Oncosec
11.17.1 Oncosec Company Information
11.17.2 Oncosec Gene Therapy in Oncology Product Offered
11.17.3 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Oncosec Main Business Overview
11.17.5 Oncosec Latest Developments
11.18 Oncotelic
11.18.1 Oncotelic Company Information
11.18.2 Oncotelic Gene Therapy in Oncology Product Offered
11.18.3 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Oncotelic Main Business Overview
11.18.5 Oncotelic Latest Developments
11.19 Shenzhen SiBiono GeneTech
11.19.1 Shenzhen SiBiono GeneTech Company Information
11.19.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
11.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Shenzhen SiBiono GeneTech Main Business Overview
11.19.5 Shenzhen SiBiono GeneTech Latest Developments
11.20 Sillajen BiOthersapeutics
11.20.1 Sillajen BiOthersapeutics Company Information
11.20.2 Sillajen BiOthersapeutics Gene Therapy in Oncology Product Offered
11.20.3 Sillajen BiOthersapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Sillajen BiOthersapeutics Main Business Overview
11.20.5 Sillajen BiOthersapeutics Latest Developments
11.21 Tocagen
11.21.1 Tocagen Company Information
11.21.2 Tocagen Gene Therapy in Oncology Product Offered
11.21.3 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Tocagen Main Business Overview
11.21.5 Tocagen Latest Developments
11.22 UniQure
11.22.1 UniQure Company Information
11.22.2 UniQure Gene Therapy in Oncology Product Offered
11.22.3 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 UniQure Main Business Overview
11.22.5 UniQure Latest Developments
11.23 Ziopharm Oncology
11.23.1 Ziopharm Oncology Company Information
11.23.2 Ziopharm Oncology Gene Therapy in Oncology Product Offered
11.23.3 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Ziopharm Oncology Main Business Overview
11.23.5 Ziopharm Oncology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy in Oncology Market Size (2020-2031)
2.1.2 Gene Therapy in Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy in Oncology by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy in Oncology Segment by Type
2.2.1 Ex Vivo
2.2.2 In Vivo
2.3 Gene Therapy in Oncology Market Size by Type
2.3.1 Gene Therapy in Oncology Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy in Oncology Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics Centers
2.4.3 Research Institutes
2.5 Gene Therapy in Oncology Market Size by Application
2.5.1 Gene Therapy in Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
3 GENE THERAPY IN ONCOLOGY MARKET SIZE BY PLAYER
3.1 Gene Therapy in Oncology Market Size Market Share by Player
3.1.1 Global Gene Therapy in Oncology Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy in Oncology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY IN ONCOLOGY BY REGION
4.1 Gene Therapy in Oncology Market Size by Region (2020-2025)
4.2 Global Gene Therapy in Oncology Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy in Oncology Market Size Growth (2020-2025)
4.4 APAC Gene Therapy in Oncology Market Size Growth (2020-2025)
4.5 Europe Gene Therapy in Oncology Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy in Oncology Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy in Oncology Market Size by Country (2020-2025)
5.2 Americas Gene Therapy in Oncology Market Size by Type (2020-2025)
5.3 Americas Gene Therapy in Oncology Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy in Oncology Market Size by Region (2020-2025)
6.2 APAC Gene Therapy in Oncology Market Size by Type (2020-2025)
6.3 APAC Gene Therapy in Oncology Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy in Oncology Market Size by Country (2020-2025)
7.2 Europe Gene Therapy in Oncology Market Size by Type (2020-2025)
7.3 Europe Gene Therapy in Oncology Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy in Oncology by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy in Oncology Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy in Oncology Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY IN ONCOLOGY MARKET FORECAST
10.1 Global Gene Therapy in Oncology Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy in Oncology Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy in Oncology Forecast
10.1.3 APAC Gene Therapy in Oncology Forecast
10.1.4 Europe Gene Therapy in Oncology Forecast
10.1.5 Middle East & Africa Gene Therapy in Oncology Forecast
10.2 Americas Gene Therapy in Oncology Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy in Oncology Forecast
10.2.2 Canada Market Gene Therapy in Oncology Forecast
10.2.3 Mexico Market Gene Therapy in Oncology Forecast
10.2.4 Brazil Market Gene Therapy in Oncology Forecast
10.3 APAC Gene Therapy in Oncology Forecast by Region (2026-2031)
10.3.1 China Gene Therapy in Oncology Market Forecast
10.3.2 Japan Market Gene Therapy in Oncology Forecast
10.3.3 Korea Market Gene Therapy in Oncology Forecast
10.3.4 Southeast Asia Market Gene Therapy in Oncology Forecast
10.3.5 India Market Gene Therapy in Oncology Forecast
10.3.6 Australia Market Gene Therapy in Oncology Forecast
10.4 Europe Gene Therapy in Oncology Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy in Oncology Forecast
10.4.2 France Market Gene Therapy in Oncology Forecast
10.4.3 UK Market Gene Therapy in Oncology Forecast
10.4.4 Italy Market Gene Therapy in Oncology Forecast
10.4.5 Russia Market Gene Therapy in Oncology Forecast
10.5 Middle East & Africa Gene Therapy in Oncology Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy in Oncology Forecast
10.5.2 South Africa Market Gene Therapy in Oncology Forecast
10.5.3 Israel Market Gene Therapy in Oncology Forecast
10.5.4 Turkey Market Gene Therapy in Oncology Forecast
10.6 Global Gene Therapy in Oncology Forecast by Type (2026-2031)
10.7 Global Gene Therapy in Oncology Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy in Oncology Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Information
11.1.2 Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bristol-Myers Squibb Main Business Overview
11.1.5 Bristol-Myers Squibb Latest Developments
11.2 Cold Genesys
11.2.1 Cold Genesys Company Information
11.2.2 Cold Genesys Gene Therapy in Oncology Product Offered
11.2.3 Cold Genesys Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Cold Genesys Main Business Overview
11.2.5 Cold Genesys Latest Developments
11.3 Advantagene
11.3.1 Advantagene Company Information
11.3.2 Advantagene Gene Therapy in Oncology Product Offered
11.3.3 Advantagene Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Advantagene Main Business Overview
11.3.5 Advantagene Latest Developments
11.4 Amgen
11.4.1 Amgen Company Information
11.4.2 Amgen Gene Therapy in Oncology Product Offered
11.4.3 Amgen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Amgen Main Business Overview
11.4.5 Amgen Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Gene Therapy in Oncology Product Offered
11.5.3 AstraZeneca Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bio-Path Holdings
11.6.1 Bio-Path Holdings Company Information
11.6.2 Bio-Path Holdings Gene Therapy in Oncology Product Offered
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bio-Path Holdings Main Business Overview
11.6.5 Bio-Path Holdings Latest Developments
11.7 CRISPR Therapeutics
11.7.1 CRISPR Therapeutics Company Information
11.7.2 CRISPR Therapeutics Gene Therapy in Oncology Product Offered
11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 CRISPR Therapeutics Main Business Overview
11.7.5 CRISPR Therapeutics Latest Developments
11.8 Editas Medicine
11.8.1 Editas Medicine Company Information
11.8.2 Editas Medicine Gene Therapy in Oncology Product Offered
11.8.3 Editas Medicine Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Editas Medicine Main Business Overview
11.8.5 Editas Medicine Latest Developments
11.9 Geron Corp
11.9.1 Geron Corp Company Information
11.9.2 Geron Corp Gene Therapy in Oncology Product Offered
11.9.3 Geron Corp Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Geron Corp Main Business Overview
11.9.5 Geron Corp Latest Developments
11.10 Idera Pharmaceuticals
11.10.1 Idera Pharmaceuticals Company Information
11.10.2 Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Idera Pharmaceuticals Main Business Overview
11.10.5 Idera Pharmaceuticals Latest Developments
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Information
11.11.2 Intellia Therapeutics Gene Therapy in Oncology Product Offered
11.11.3 Intellia Therapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Intellia Therapeutics Main Business Overview
11.11.5 Intellia Therapeutics Latest Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Information
11.12.2 Johnson & Johnson Gene Therapy in Oncology Product Offered
11.12.3 Johnson & Johnson Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Johnson & Johnson Main Business Overview
11.12.5 Johnson & Johnson Latest Developments
11.13 Marsala Biotech
11.13.1 Marsala Biotech Company Information
11.13.2 Marsala Biotech Gene Therapy in Oncology Product Offered
11.13.3 Marsala Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Marsala Biotech Main Business Overview
11.13.5 Marsala Biotech Latest Developments
11.14 Merck
11.14.1 Merck Company Information
11.14.2 Merck Gene Therapy in Oncology Product Offered
11.14.3 Merck Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Merck Main Business Overview
11.14.5 Merck Latest Developments
11.15 Mologen AG
11.15.1 Mologen AG Company Information
11.15.2 Mologen AG Gene Therapy in Oncology Product Offered
11.15.3 Mologen AG Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Mologen AG Main Business Overview
11.15.5 Mologen AG Latest Developments
11.16 Oncolytics Biotech
11.16.1 Oncolytics Biotech Company Information
11.16.2 Oncolytics Biotech Gene Therapy in Oncology Product Offered
11.16.3 Oncolytics Biotech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Oncolytics Biotech Main Business Overview
11.16.5 Oncolytics Biotech Latest Developments
11.17 Oncosec
11.17.1 Oncosec Company Information
11.17.2 Oncosec Gene Therapy in Oncology Product Offered
11.17.3 Oncosec Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Oncosec Main Business Overview
11.17.5 Oncosec Latest Developments
11.18 Oncotelic
11.18.1 Oncotelic Company Information
11.18.2 Oncotelic Gene Therapy in Oncology Product Offered
11.18.3 Oncotelic Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Oncotelic Main Business Overview
11.18.5 Oncotelic Latest Developments
11.19 Shenzhen SiBiono GeneTech
11.19.1 Shenzhen SiBiono GeneTech Company Information
11.19.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
11.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Shenzhen SiBiono GeneTech Main Business Overview
11.19.5 Shenzhen SiBiono GeneTech Latest Developments
11.20 Sillajen BiOthersapeutics
11.20.1 Sillajen BiOthersapeutics Company Information
11.20.2 Sillajen BiOthersapeutics Gene Therapy in Oncology Product Offered
11.20.3 Sillajen BiOthersapeutics Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Sillajen BiOthersapeutics Main Business Overview
11.20.5 Sillajen BiOthersapeutics Latest Developments
11.21 Tocagen
11.21.1 Tocagen Company Information
11.21.2 Tocagen Gene Therapy in Oncology Product Offered
11.21.3 Tocagen Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Tocagen Main Business Overview
11.21.5 Tocagen Latest Developments
11.22 UniQure
11.22.1 UniQure Company Information
11.22.2 UniQure Gene Therapy in Oncology Product Offered
11.22.3 UniQure Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.22.4 UniQure Main Business Overview
11.22.5 UniQure Latest Developments
11.23 Ziopharm Oncology
11.23.1 Ziopharm Oncology Company Information
11.23.2 Ziopharm Oncology Gene Therapy in Oncology Product Offered
11.23.3 Ziopharm Oncology Gene Therapy in Oncology Revenue, Gross Margin and Market Share (2020-2025)
11.23.4 Ziopharm Oncology Main Business Overview
11.23.5 Ziopharm Oncology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy in Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy in Oncology Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ex Vivo
Table 4. Major Players of In Vivo
Table 5. Gene Therapy in Oncology Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Table 8. Gene Therapy in Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Therapy in Oncology Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Therapy in Oncology Revenue Market Share by Player (2020-2025)
Table 13. Gene Therapy in Oncology Key Players Head office and Products Offered
Table 14. Gene Therapy in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy in Oncology Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Therapy in Oncology Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Therapy in Oncology Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Therapy in Oncology Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Therapy in Oncology Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Therapy in Oncology Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Therapy in Oncology Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Therapy in Oncology Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Therapy in Oncology Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy in Oncology
Table 39. Key Market Challenges & Risks of Gene Therapy in Oncology
Table 40. Key Industry Trends of Gene Therapy in Oncology
Table 41. Global Gene Therapy in Oncology Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Therapy in Oncology Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Therapy in Oncology Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Therapy in Oncology Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Bristol-Myers Squibb Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 46. Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
Table 47. Bristol-Myers Squibb Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Bristol-Myers Squibb Main Business
Table 49. Bristol-Myers Squibb Latest Developments
Table 50. Cold Genesys Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 51. Cold Genesys Gene Therapy in Oncology Product Offered
Table 52. Cold Genesys Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Cold Genesys Main Business
Table 54. Cold Genesys Latest Developments
Table 55. Advantagene Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 56. Advantagene Gene Therapy in Oncology Product Offered
Table 57. Advantagene Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Advantagene Main Business
Table 59. Advantagene Latest Developments
Table 60. Amgen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 61. Amgen Gene Therapy in Oncology Product Offered
Table 62. Amgen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Amgen Main Business
Table 64. Amgen Latest Developments
Table 65. AstraZeneca Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 66. AstraZeneca Gene Therapy in Oncology Product Offered
Table 67. AstraZeneca Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. AstraZeneca Main Business
Table 69. AstraZeneca Latest Developments
Table 70. Bio-Path Holdings Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 71. Bio-Path Holdings Gene Therapy in Oncology Product Offered
Table 72. Bio-Path Holdings Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Bio-Path Holdings Main Business
Table 74. Bio-Path Holdings Latest Developments
Table 75. CRISPR Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 76. CRISPR Therapeutics Gene Therapy in Oncology Product Offered
Table 77. CRISPR Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CRISPR Therapeutics Main Business
Table 79. CRISPR Therapeutics Latest Developments
Table 80. Editas Medicine Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 81. Editas Medicine Gene Therapy in Oncology Product Offered
Table 82. Editas Medicine Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Editas Medicine Main Business
Table 84. Editas Medicine Latest Developments
Table 85. Geron Corp Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 86. Geron Corp Gene Therapy in Oncology Product Offered
Table 87. Geron Corp Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Geron Corp Main Business
Table 89. Geron Corp Latest Developments
Table 90. Idera Pharmaceuticals Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 91. Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
Table 92. Idera Pharmaceuticals Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Idera Pharmaceuticals Main Business
Table 94. Idera Pharmaceuticals Latest Developments
Table 95. Intellia Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 96. Intellia Therapeutics Gene Therapy in Oncology Product Offered
Table 97. Intellia Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Intellia Therapeutics Main Business
Table 99. Intellia Therapeutics Latest Developments
Table 100. Johnson & Johnson Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 101. Johnson & Johnson Gene Therapy in Oncology Product Offered
Table 102. Johnson & Johnson Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Johnson & Johnson Main Business
Table 104. Johnson & Johnson Latest Developments
Table 105. Marsala Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 106. Marsala Biotech Gene Therapy in Oncology Product Offered
Table 107. Marsala Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Marsala Biotech Main Business
Table 109. Marsala Biotech Latest Developments
Table 110. Merck Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 111. Merck Gene Therapy in Oncology Product Offered
Table 112. Merck Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Merck Main Business
Table 114. Merck Latest Developments
Table 115. Mologen AG Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 116. Mologen AG Gene Therapy in Oncology Product Offered
Table 117. Mologen AG Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Mologen AG Main Business
Table 119. Mologen AG Latest Developments
Table 120. Oncolytics Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 121. Oncolytics Biotech Gene Therapy in Oncology Product Offered
Table 122. Oncolytics Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Oncolytics Biotech Main Business
Table 124. Oncolytics Biotech Latest Developments
Table 125. Oncosec Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 126. Oncosec Gene Therapy in Oncology Product Offered
Table 127. Oncosec Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Oncosec Main Business
Table 129. Oncosec Latest Developments
Table 130. Oncotelic Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 131. Oncotelic Gene Therapy in Oncology Product Offered
Table 132. Oncotelic Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Oncotelic Main Business
Table 134. Oncotelic Latest Developments
Table 135. Shenzhen SiBiono GeneTech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 136. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
Table 137. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Shenzhen SiBiono GeneTech Main Business
Table 139. Shenzhen SiBiono GeneTech Latest Developments
Table 140. Sillajen BiOthersapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 141. Sillajen BiOthersapeutics Gene Therapy in Oncology Product Offered
Table 142. Sillajen BiOthersapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Sillajen BiOthersapeutics Main Business
Table 144. Sillajen BiOthersapeutics Latest Developments
Table 145. Tocagen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 146. Tocagen Gene Therapy in Oncology Product Offered
Table 147. Tocagen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Tocagen Main Business
Table 149. Tocagen Latest Developments
Table 150. UniQure Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 151. UniQure Gene Therapy in Oncology Product Offered
Table 152. UniQure Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. UniQure Main Business
Table 154. UniQure Latest Developments
Table 155. Ziopharm Oncology Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 156. Ziopharm Oncology Gene Therapy in Oncology Product Offered
Table 157. Ziopharm Oncology Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 158. Ziopharm Oncology Main Business
Table 159. Ziopharm Oncology Latest Developments
Table 1. Gene Therapy in Oncology Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy in Oncology Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ex Vivo
Table 4. Major Players of In Vivo
Table 5. Gene Therapy in Oncology Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Table 8. Gene Therapy in Oncology Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Therapy in Oncology Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Therapy in Oncology Revenue Market Share by Player (2020-2025)
Table 13. Gene Therapy in Oncology Key Players Head office and Products Offered
Table 14. Gene Therapy in Oncology Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy in Oncology Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Therapy in Oncology Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Therapy in Oncology Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Therapy in Oncology Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Therapy in Oncology Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Therapy in Oncology Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Therapy in Oncology Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Therapy in Oncology Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Therapy in Oncology Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapy in Oncology Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapy in Oncology Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy in Oncology
Table 39. Key Market Challenges & Risks of Gene Therapy in Oncology
Table 40. Key Industry Trends of Gene Therapy in Oncology
Table 41. Global Gene Therapy in Oncology Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Therapy in Oncology Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Therapy in Oncology Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Therapy in Oncology Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Bristol-Myers Squibb Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 46. Bristol-Myers Squibb Gene Therapy in Oncology Product Offered
Table 47. Bristol-Myers Squibb Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Bristol-Myers Squibb Main Business
Table 49. Bristol-Myers Squibb Latest Developments
Table 50. Cold Genesys Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 51. Cold Genesys Gene Therapy in Oncology Product Offered
Table 52. Cold Genesys Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Cold Genesys Main Business
Table 54. Cold Genesys Latest Developments
Table 55. Advantagene Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 56. Advantagene Gene Therapy in Oncology Product Offered
Table 57. Advantagene Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Advantagene Main Business
Table 59. Advantagene Latest Developments
Table 60. Amgen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 61. Amgen Gene Therapy in Oncology Product Offered
Table 62. Amgen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Amgen Main Business
Table 64. Amgen Latest Developments
Table 65. AstraZeneca Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 66. AstraZeneca Gene Therapy in Oncology Product Offered
Table 67. AstraZeneca Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. AstraZeneca Main Business
Table 69. AstraZeneca Latest Developments
Table 70. Bio-Path Holdings Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 71. Bio-Path Holdings Gene Therapy in Oncology Product Offered
Table 72. Bio-Path Holdings Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Bio-Path Holdings Main Business
Table 74. Bio-Path Holdings Latest Developments
Table 75. CRISPR Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 76. CRISPR Therapeutics Gene Therapy in Oncology Product Offered
Table 77. CRISPR Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. CRISPR Therapeutics Main Business
Table 79. CRISPR Therapeutics Latest Developments
Table 80. Editas Medicine Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 81. Editas Medicine Gene Therapy in Oncology Product Offered
Table 82. Editas Medicine Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Editas Medicine Main Business
Table 84. Editas Medicine Latest Developments
Table 85. Geron Corp Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 86. Geron Corp Gene Therapy in Oncology Product Offered
Table 87. Geron Corp Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Geron Corp Main Business
Table 89. Geron Corp Latest Developments
Table 90. Idera Pharmaceuticals Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 91. Idera Pharmaceuticals Gene Therapy in Oncology Product Offered
Table 92. Idera Pharmaceuticals Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Idera Pharmaceuticals Main Business
Table 94. Idera Pharmaceuticals Latest Developments
Table 95. Intellia Therapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 96. Intellia Therapeutics Gene Therapy in Oncology Product Offered
Table 97. Intellia Therapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Intellia Therapeutics Main Business
Table 99. Intellia Therapeutics Latest Developments
Table 100. Johnson & Johnson Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 101. Johnson & Johnson Gene Therapy in Oncology Product Offered
Table 102. Johnson & Johnson Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Johnson & Johnson Main Business
Table 104. Johnson & Johnson Latest Developments
Table 105. Marsala Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 106. Marsala Biotech Gene Therapy in Oncology Product Offered
Table 107. Marsala Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Marsala Biotech Main Business
Table 109. Marsala Biotech Latest Developments
Table 110. Merck Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 111. Merck Gene Therapy in Oncology Product Offered
Table 112. Merck Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Merck Main Business
Table 114. Merck Latest Developments
Table 115. Mologen AG Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 116. Mologen AG Gene Therapy in Oncology Product Offered
Table 117. Mologen AG Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Mologen AG Main Business
Table 119. Mologen AG Latest Developments
Table 120. Oncolytics Biotech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 121. Oncolytics Biotech Gene Therapy in Oncology Product Offered
Table 122. Oncolytics Biotech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. Oncolytics Biotech Main Business
Table 124. Oncolytics Biotech Latest Developments
Table 125. Oncosec Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 126. Oncosec Gene Therapy in Oncology Product Offered
Table 127. Oncosec Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Oncosec Main Business
Table 129. Oncosec Latest Developments
Table 130. Oncotelic Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 131. Oncotelic Gene Therapy in Oncology Product Offered
Table 132. Oncotelic Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Oncotelic Main Business
Table 134. Oncotelic Latest Developments
Table 135. Shenzhen SiBiono GeneTech Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 136. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product Offered
Table 137. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. Shenzhen SiBiono GeneTech Main Business
Table 139. Shenzhen SiBiono GeneTech Latest Developments
Table 140. Sillajen BiOthersapeutics Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 141. Sillajen BiOthersapeutics Gene Therapy in Oncology Product Offered
Table 142. Sillajen BiOthersapeutics Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Sillajen BiOthersapeutics Main Business
Table 144. Sillajen BiOthersapeutics Latest Developments
Table 145. Tocagen Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 146. Tocagen Gene Therapy in Oncology Product Offered
Table 147. Tocagen Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 148. Tocagen Main Business
Table 149. Tocagen Latest Developments
Table 150. UniQure Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 151. UniQure Gene Therapy in Oncology Product Offered
Table 152. UniQure Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 153. UniQure Main Business
Table 154. UniQure Latest Developments
Table 155. Ziopharm Oncology Details, Company Type, Gene Therapy in Oncology Area Served and Its Competitors
Table 156. Ziopharm Oncology Gene Therapy in Oncology Product Offered
Table 157. Ziopharm Oncology Gene Therapy in Oncology Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 158. Ziopharm Oncology Main Business
Table 159. Ziopharm Oncology Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy in Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in Oncology Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy in Oncology Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy in Oncology Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy in Oncology Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy in Oncology Market Size Market Share by Type in 2024
Figure 10. Gene Therapy in Oncology in Hospitals
Figure 11. Global Gene Therapy in Oncology Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Gene Therapy in Oncology in Diagnostics Centers
Figure 13. Global Gene Therapy in Oncology Market: Diagnostics Centers (2020-2025) & ($ millions)
Figure 14. Gene Therapy in Oncology in Research Institutes
Figure 15. Global Gene Therapy in Oncology Market: Research Institutes (2020-2025) & ($ millions)
Figure 16. Global Gene Therapy in Oncology Market Size Market Share by Application in 2024
Figure 17. Global Gene Therapy in Oncology Revenue Market Share by Player in 2024
Figure 18. Global Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Therapy in Oncology Value Market Share by Country in 2024
Figure 24. United States Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Therapy in Oncology Market Size Market Share by Region in 2024
Figure 29. APAC Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Therapy in Oncology Market Size Market Share by Country in 2024
Figure 38. Europe Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 61. China Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 65. India Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 68. France Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Therapy in Oncology Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gene Therapy in Oncology Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 1. Gene Therapy in Oncology Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy in Oncology Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy in Oncology Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy in Oncology Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy in Oncology Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy in Oncology Market Size Market Share by Type in 2024
Figure 10. Gene Therapy in Oncology in Hospitals
Figure 11. Global Gene Therapy in Oncology Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Gene Therapy in Oncology in Diagnostics Centers
Figure 13. Global Gene Therapy in Oncology Market: Diagnostics Centers (2020-2025) & ($ millions)
Figure 14. Gene Therapy in Oncology in Research Institutes
Figure 15. Global Gene Therapy in Oncology Market: Research Institutes (2020-2025) & ($ millions)
Figure 16. Global Gene Therapy in Oncology Market Size Market Share by Application in 2024
Figure 17. Global Gene Therapy in Oncology Revenue Market Share by Player in 2024
Figure 18. Global Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Therapy in Oncology Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Therapy in Oncology Value Market Share by Country in 2024
Figure 24. United States Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Therapy in Oncology Market Size Market Share by Region in 2024
Figure 29. APAC Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Therapy in Oncology Market Size Market Share by Country in 2024
Figure 38. Europe Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gene Therapy in Oncology Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Therapy in Oncology Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 61. China Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 65. India Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 68. France Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Therapy in Oncology Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gene Therapy in Oncology Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gene Therapy in Oncology Market Size 2026-2031 ($ millions)
